Latest Breaking News On - Melanoma research alliance medical advisory panel - Page 1 : vimarsana.com

04.01.2024 - WATERTOWN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) - Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of novel, conditionally activated INDUKINE therapeutics .

United statesWilliamm schollEllen lubmanMichael atkinsMelanoma research alliance medical advisory panelSociety for the immunotherapy of cancerVerge scientific communicationsProfessor at harvard medical schoolAdvisory councilCancer centerWerewolf therapeutics incCompany contactAcademy of immunooncologyWerewolf boardDeputy directorGeorgetown lombardi comprehensive cancer center